ArticleAesthetic plastic surgery2026
Efficacy Analysis of Transconjunctival Blepharoplasty Combined with Nanofat Grafting in Correcting Tear Trough Deformity.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundTear trough deformity often coexists with lower eyelid bags. While transconjunctival blepharoplasty combined with autologous fat grafting is effective, the optimal preparation method-conventional fat versus nanofat-remains unclear. This study compares the efficacy and safety of these two techniques.
methodsA retrospective cohort study was conducted on 87 patients who underwent transconjunctival blepharoplasty combined with either granular fat (Group A, n = 41) or nanofat grafting (Group B, n = 46). Outcomes were assessed at 6 months postoperatively using patient satisfaction scores, Barton grade improvement, tear trough height-to-palpebral fissure width (TTDH/PFW) ratio, lower eyelid pigmentation scores, and complication rates.
resultsBoth groups showed significant improvement. However, for mild-to-moderate deformity, Group B demonstrated superior outcomes: higher patient satisfaction (P < 0.001), greater reduction in TTDH/PFW (P < 0.05), and significant improvement in lower eyelid pigmentation (P < 0.001). Group B also had a significantly lower complication rate. No significant difference was found for severe deformity.
conclusionFor mild-to-moderate tear trough deformity, nanofat grafting combined with transconjunctival blepharoplasty provides more effective and comprehensive correction-improving contour, reducing pigmentation, and resulting in fewer complications-compared to conventional macrofat grafting. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42864539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.